TY - JOUR
T1 - Efferocytosis and Bone Dynamics
AU - Batoon, Lena
AU - Hawse, John R.
AU - McCauley, Laurie K.
AU - Weivoda, Megan M.
AU - Roca, Hernan
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.
PY - 2024/10
Y1 - 2024/10
N2 - Purpose of Review: This review summarizes the recently published scientific evidence regarding the role of efferocytosis in bone dynamics and skeletal health. Recent Findings: Several types of efferocytes have been identified within the skeleton, with macrophages being the most extensively studied. Efferocytosis is not merely a 'clean-up' process vital for maintaining skeletal homeostasis; it also plays a crucial role in promoting resolution pathways and orchestrating bone dynamics, such as osteoblast-osteoclast coupling during bone remodeling. Impaired efferocytosis has been associated with aging-related bone loss and various skeletal pathologies, including osteoporosis, osteoarthritis, rheumatoid arthritis, and metastatic bone diseases. Accordingly, emerging evidence suggests that targeting efferocytic mechanisms has the potential to alleviate these conditions. Summary: While efferocytosis remains underexplored in the skeleton, recent discoveries have shed light on its pivotal role in bone dynamics, with important implications for skeletal health and pathology. However, there are several knowledge gaps and persisting technical limitations that must be addressed to fully unveil the contributions of efferocytosis in bone.
AB - Purpose of Review: This review summarizes the recently published scientific evidence regarding the role of efferocytosis in bone dynamics and skeletal health. Recent Findings: Several types of efferocytes have been identified within the skeleton, with macrophages being the most extensively studied. Efferocytosis is not merely a 'clean-up' process vital for maintaining skeletal homeostasis; it also plays a crucial role in promoting resolution pathways and orchestrating bone dynamics, such as osteoblast-osteoclast coupling during bone remodeling. Impaired efferocytosis has been associated with aging-related bone loss and various skeletal pathologies, including osteoporosis, osteoarthritis, rheumatoid arthritis, and metastatic bone diseases. Accordingly, emerging evidence suggests that targeting efferocytic mechanisms has the potential to alleviate these conditions. Summary: While efferocytosis remains underexplored in the skeleton, recent discoveries have shed light on its pivotal role in bone dynamics, with important implications for skeletal health and pathology. However, there are several knowledge gaps and persisting technical limitations that must be addressed to fully unveil the contributions of efferocytosis in bone.
KW - Bone phagocytes
KW - Efferocytes
KW - Efferocytosis
KW - Efferocytosis in bone
KW - Macrophages
UR - http://www.scopus.com/inward/record.url?scp=85196719806&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85196719806&partnerID=8YFLogxK
U2 - 10.1007/s11914-024-00878-y
DO - 10.1007/s11914-024-00878-y
M3 - Review article
C2 - 38914730
AN - SCOPUS:85196719806
SN - 1544-1873
VL - 22
SP - 471
EP - 482
JO - Current osteoporosis reports
JF - Current osteoporosis reports
IS - 5
ER -